Jennifer Rachel Cochran
Affiliations: | Bioengineering | Stanford University, Palo Alto, CA |
Area:
BioengineeringWebsite:
https://profiles.stanford.edu/jennifer-cochranGoogle:
"Jennifer Rachel Cochran"Bio:
https://books.google.com/books?id=k4gvAQAAIAAJ
https://kdw-lab.mit.edu/members/alumni/
Mean distance: 106866
Cross-listing: E-Tree
Parents
Sign in to add mentorLawrence J. Stern | grad student | 2001 | MIT (Chemistry Tree) | |
(The molecular mechanism of T cell activation investigated with class II MHC oligomers.) | ||||
K. Dane Wittrup | post-doc | 2002-2004 | MIT (Chemistry Tree) | |
William F. DeGrado | post-doc | 2004-2005 | UCSF (Chemistry Tree) |
Children
Sign in to add traineePing-Chuan (Christina) Tsai | post-doc | 2010-2012 | Stanford Medical School (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Silberstein JL, Du J, Chan KW, et al. (2024) Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function. Proceedings of the National Academy of Sciences of the United States of America. 121: e2310866121 |
Murty S, Labanieh L, Murty T, et al. (2020) PET reporter gene imaging and ganciclovir-mediated ablation of chimeric antigen receptor T-cells in solid tumors. Cancer Research |
Mehta N, Maddineni S, Kelly RL, et al. (2020) An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA. Scientific Reports. 10: 15171 |
Kim JW, Marquez CP, Sperberg RAP, et al. (2020) Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand. Proceedings of the National Academy of Sciences of the United States of America |
Kim JW, Marquez CP, Kostyrko K, et al. (2019) Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma. Nature Medicine |
Mehta N, Maddineni S, Mathews II, et al. (2019) Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation. Cell Reports. 28: 2509-2516.e5 |
Van Agthoven JF, Shams H, Cochran FV, et al. (2019) Structural Basis of the Differential Binding of Engineered Knottins to Integrins αVβ3 and α5β1. Structure (London, England : 1993) |
Mitchell AC, Kannan D, Hunter SA, et al. (2018) Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein. The Journal of Biological Chemistry |
Marquez C, Kim J, Giaccia A, et al. (2018) Abstract 3918: Targeting the CLCF1-CNTFR signaling axis using directed evolution for lung cancer therapy Cancer Research. 78: 3918-3918 |
Thayaparan T, Petrovic RM, Achkova DY, et al. (2017) CAR T-cell immunotherapy of MET-expressing malignant mesothelioma. Oncoimmunology. 6: e1363137 |